Intrauterine supraventricular tachycardia: cardioversion with maternal digoxin. 1982

F C Heaton, and R Vaughan

Intrauterine supraventricular tachycardia is an uncommon cardiac arrhythmia that presents difficult problems in diagnosis and management, especially in the very preterm infant. Serial ultrasound examinations were used to follow the course of fetal ascites and the maternal administration of digoxin to induce cardioversion. Higher maternal doses of digoxin than administered to the nonpregnant patient may be necessary to achieve adequate digitalization of the fetus. As many infants with supraventricular tachycardia require continued medical management, they should be delivered in a facility with neonatal intensive care capabilities.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008297 Male Males
D008431 Maternal-Fetal Exchange Exchange of substances between the maternal blood and the fetal blood at the PLACENTA via PLACENTAL CIRCULATION. The placental barrier excludes microbial or viral transmission. Transplacental Exposure,Exchange, Maternal-Fetal,Exposure, Transplacental,Maternal Fetal Exchange
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D004077 Digoxin A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666) Digacin,Digitek,Digoregen,Digoxina Boehringer,Digoxine Nativelle,Dilanacin,Hemigoxine Nativelle,Lanacordin,Lanicor,Lanoxicaps,Lanoxin,Lanoxin-PG,Lenoxin,Mapluxin,Boehringer, Digoxina,Lanoxin PG,Nativelle, Digoxine,Nativelle, Hemigoxine
D005260 Female Females
D005315 Fetal Diseases Pathophysiological conditions of the FETUS in the UTERUS. Some fetal diseases may be treated with FETAL THERAPIES. Embryopathies,Disease, Fetal,Diseases, Fetal,Embryopathy,Fetal Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001201 Ascites Accumulation or retention of free fluid within the peritoneal cavity.

Related Publications

F C Heaton, and R Vaughan
August 1986, The Journal of reproductive medicine,
F C Heaton, and R Vaughan
August 1980, Lancet (London, England),
F C Heaton, and R Vaughan
January 1984, Journal of perinatal medicine,
F C Heaton, and R Vaughan
January 1993, Zeitschrift fur Geburtshilfe und Perinatologie,
F C Heaton, and R Vaughan
March 1986, The Journal of reproductive medicine,
F C Heaton, and R Vaughan
February 1985, The Journal of reproductive medicine,
F C Heaton, and R Vaughan
October 1986, European journal of pediatrics,
F C Heaton, and R Vaughan
September 1995, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
F C Heaton, and R Vaughan
January 1985, Pediatric pharmacology (New York, N.Y.),
Copied contents to your clipboard!